CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies.
CV6 Therapeutics has raised $5.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2022.
CV6 Therapeutics's investors include Clarendon Fund Managers, Techstart Ventures, QUBIS, Invest Northern Ireland, Co-FundNI.
CV6 Therapeutics is headquartered in Belfast, United Kingdom.
CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies.
CV6 Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CV6 Therapeutics — Funding & Investors." VCBacked, November 2, 2022, https://www.vcbacked.co/company/cv6-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). CV6 Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cv6-therapeutics
{{cite web |title=CV6 Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cv6-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated